International study on prevalence of itch: examining the role of itch as a major global public health problem.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
20 Jun 2024
Historique:
received: 30 10 2023
revised: 05 06 2024
accepted: 17 06 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

Very few studies evaluated the global prevalence of pruritus. To assess its prevalence according to age, gender, ethnicity, and geographic regions. An international cross-sectional study was conducted in 20 countries from January to April 2023. Participants were asked to complete a questionnaire on sociodemographics, confirm the presence or absence of a skin disease in the last 12 months and the presence or absence of pruritus in the last 7 days. The studied sample included 50552 individuals. The worldwide prevalence of pruritus was 39.8%. The age group ≥65 had the highest prevalence (43.3%). The prevalence was 40.7% among women and 38.9% among men (p<0.001). There was no significant difference between ethnicities (p=0.14). Compared to North America (41.6%), the prevalence of pruritus was significantly lower in Europe (35.9%, p<0.001), Australia (38.4%, p=0.017), East Asia (40.2%, p=0.04), and Latin America (36.5%, p<0.001), and higher in Africa (45,7%, p=0.007). No significant difference was found with the Middle East (40.2%, p=0.36). The prevalence was 40.3% in developed countries and 38.7% in BRICS countries 40.7% (p<10-3). No information about the severity or type (acute, chronic) of pruritus. Global prevalence of pruritus revealed age, gender, and geographic region differences, with no ethnic differences.

Sections du résumé

BACKGROUND BACKGROUND
Very few studies evaluated the global prevalence of pruritus.
OBJECTIVE OBJECTIVE
To assess its prevalence according to age, gender, ethnicity, and geographic regions.
METHODS METHODS
An international cross-sectional study was conducted in 20 countries from January to April 2023. Participants were asked to complete a questionnaire on sociodemographics, confirm the presence or absence of a skin disease in the last 12 months and the presence or absence of pruritus in the last 7 days.
RESULTS RESULTS
The studied sample included 50552 individuals. The worldwide prevalence of pruritus was 39.8%. The age group ≥65 had the highest prevalence (43.3%). The prevalence was 40.7% among women and 38.9% among men (p<0.001). There was no significant difference between ethnicities (p=0.14). Compared to North America (41.6%), the prevalence of pruritus was significantly lower in Europe (35.9%, p<0.001), Australia (38.4%, p=0.017), East Asia (40.2%, p=0.04), and Latin America (36.5%, p<0.001), and higher in Africa (45,7%, p=0.007). No significant difference was found with the Middle East (40.2%, p=0.36). The prevalence was 40.3% in developed countries and 38.7% in BRICS countries 40.7% (p<10-3).
LIMITATIONS CONCLUSIONS
No information about the severity or type (acute, chronic) of pruritus.
CONCLUSION CONCLUSIONS
Global prevalence of pruritus revealed age, gender, and geographic region differences, with no ethnic differences.

Identifiants

pubmed: 38900904
pii: 7696669
doi: 10.1093/bjd/ljae260
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of British Association of Dermatologists.

Auteurs

Gil Yosipovitch (G)

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Charbel Skayem (C)

Sorbonne University, Faculty of Medicine, Paris, France.
Hôpitaux de Paris (AP-HP), Paris Saclay University, Ambroise Paré Hospital, Boulogne Billancourt, France.

Marketa Saint Aroman (M)

Corporate Medical Direction Pharma, Dermocosmetics Care & Personal Care, Pierre Fabre, Toulouse, France.

Charles Taieb (C)

Patients Priority Dpt, EMMA, Paris, France.

Medhi Inane (M)

European Market Maintenance Assessment (EMMA), Paris, France.

Yaron Ben Hayoun (Y)

European Market Maintenance Assessment (EMMA), Tel Aviv, Israel.

Nuria Perez Cullel (NP)

Dermocosmetics Care & Personal Care, Pierre Fabre, Toulouse, France.

Catherine Baissac (C)

Patient Centricity Department, Pharma, Dermocosmetics Care & Personal Care, Pierre Fabre, Toulouse, France.

Bruno Halioua (B)

Dermatologist, Paris, France.
Société Française des Sciences Humaines de la Peau, Président, Maison de la Dermatologie, Paris, France.

Marie Aleth Richard (MA)

CEReSS-EA 3279, Centre d'études et de recherches sur les services de santé et la qualité de vie, Aix Marseille Université, service de dermatologie, CHU de la Timone, APHM, Marseille, France.

Laurent Misery (L)

Univ Brest, LIEN, Brest, France.
Department of Dermatology, Venereology and Allergology and French Expert Centre on Pruritus, University Hospital of Brest, Brest, France.

Classifications MeSH